Eden Research plc (AIM:EDEN)

Market Cap	27.72M +31.6%
Revenue (ttm)	3.62M -8.1%
Net Income	-2.35M
EPS	-0.00
Shares Out	803.36M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	28,739
Open	3.315
Previous Close	3.450
Day's Range	3.315 - 3.522
52-Week Range	1.960 - 5.000
Beta	1.76
Analysts	n/a
Price Target	n/a
Earnings Date	May 20, 2026

About Eden Research

Eden Research plc, together with its subsidiaries, engages in the development and sale of biopesticides in Europe and the United Kingdom. The company offers foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatments under the Mevalone and Cedroz brands for crop protection applications. It also provides consume products, such as head-lice treatment, deodorants, odour neutralizer, and fragrances, as well as food flavourings and active ingredients; and animal health products co...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1995
• Employees: 23
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: EDEN

Financial Performance

In 2024, Eden Research's revenue was 4.30 million, an increase of 34.79% compared to the previous year's 3.19 million. Losses were -1.91 million, -70.64% less than in 2023.